Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
Aim. To compare efficiency of two regimes of basal therapy with human insulin analogs glargin (Lantus) once daily and detemir (Levemir) twicedaily based on their hypoglycemic action (HbA1c
Saved in:
| Main Authors: | Alsu Gafurovna Zalevskaya, Nelli Il'inichna Verbovaya, Tatiana Igorevna Rodionova, Olga Konstantinovna Vikulova, Marina Vladimirovna Shestakova |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-06-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5685 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL AND ECONOMIC BENEFITS OF HUMAN INSULIN ANALOGUESUSE
by: E. E. Arinina, et al.
Published: (2015-03-01) -
Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
by: Tamara Leonidovna Kuraeva
Published: (2014-07-01) -
Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01) -
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01) -
Survival following intentional overdose of veterinary insulin: A case report
by: Elsa Sandeno, et al.
Published: (2025-12-01)